In this presentation, we explore the rapid growth of the CAR T market, driven by oncology advancements and innovative clinical applications. Key challenges in CAR T manufacturing, such as supply capacity and manual processes, are addressed through Lanza's Cocoon platform. This automated solution consolidates manufacturing steps, reduces vein-to-vein time, and enhances product quality. The presentation highlights the platform's components, the rapid manufacturing process, and its effectiveness in producing robust CAR T cells. Watch the video to learn more.

Speaker: Tamara Laskowski, PhD, Senior Director, Clinical Development

By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest content
Latest briefing from the Knowledge Center